This study is testing a vaginal insert called ABI-2280 to see if it can safely clear persistent, high-risk HPV infections in women. About 141 women aged 25-55 with a long-term HPV infection will receive either the active insert or a placebo. The main goal is to see if the treatme…
Phase: PHASE1, PHASE2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC